GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?

This article aims to provide a comprehensive overview of current knowledge regarding the possible positive effects of GLP-1 RA in the treatment of T1DM patients. PMID: 26438316 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26438316?dopt=Abstract

Source: Current Pharmaceutical Design - October 6, 2015 Category: Drugs & Pharmacology Authors: Popovic DS, Stokic E, Popovic SL Tags: Curr Pharm Des Source Type: research